U.S. FDA Fast Track designation granted to ZW191, an antibody-drug conjugate targeting folate receptor-α (FRα), for the treatment of patients with advanced or metastatic platinum-resistant ovarian......
DUBLIN, March 30, 2026 (GLOBE NEWSWIRE) -- As companies face increasing pressure from investors, regulators and ESG commitments to reduce their carbon footprint, corporate travel is emerging as an are......
